PPD

👋 #ACR24: Stop by booth 2604 and meet our clinical trials experts at American College of Rheumatology (ACR) Convergence 2024, happening in Washington, D.C. This is the place “Where Rheumatology Meets” — uniting experts, innovators and leaders from around the globe. Whether you're looking to learn, collaborate or simply connect, we can’t wait to meet you! Let’s advance rheumatology together. #WhereRheumatologyMeets #clinicaltrials #rheumatology

📢 #AHA24: We're excited to be at the heart of #cardiovascular clinical development in Chicago this weekend! Meet our experts (and enjoy a cookie! 🍪) at booth 1720.

Narcisa MESAROS, MD brings a wealth of R&D experience to her role, and as a physician, she understands the vital importance of timely project delivery, meeting customers' needs and delivering exceptional quality. Connect with Narcisa and our team of #vaccine experts. » https://bit.ly/3LtLYng

Discover how #AI and real-world data (RWD) are revolutionizing drug development. This blog delves into the transformative power of AI and RWD in the future of drug development. Learn how these technologies are driving #innovation, improving outcomes and accelerating the #drugdevelopment process.

📅 Join us on Wednesday, Nov. 20 for an insightful webinar on managing scientific risks in #dermatology trials. In this webinar, experts Michael E. Kuligowski, MD, PhD, MBA, Rakhi Kilaru, Amy Kroeplin and Alessandro Maio will explore the utility of scientific surveillance, which integrates statistical, scientific and clinical insights to safeguard data integrity in clinical trials. Discover the importance of applying scientific scrutiny to dermatology #clinicaltrials through scientific surveillance, as well as its broader applicability across all areas of clinical research, and gain valuable insights into the latest research, methodologies and case studies. Register today to secure your spot! ⬇️

We look forward to attending the American College of Rheumatology (#ACR) Convergence in Washington, D.C.! Nora Carroll PhD MPH will be presenting a poster on using real-world data to model diversity in systemic lupus erythematosus (SLE) clinical trials on Sunday, Nov. 17 from 10:30 a.m.-12:30 p.m. Can’t make the presentation? Visit us at booth 2604, or pre-arrange a meeting with our team. » https://bit.ly/4hH2lvX

Today's clinical research data landscape is nothing short of complex. We deliver more than innovative data solutions. Our data solutions go beyond stats and figures. We provide a truly customized approach that yields data-driven insights, enabling our customers to move confidently through the drug development journey. 📊 » https://bit.ly/3QEXyQx

From molecule to market: We provide customers with expertise and unparalleled resources for all phases of drug development and manufacturing, from early development through clinical research and commercialization. This is Accelerator™ Drug Development, Thermo Fisher Scientific's 360° contract development and manufacturing organization (CDMO) and contract research organization (CRO) drug development solutions. Email Chelsea.Arthurs@ppd.com to schedule a meeting with our team at #JefferiesHealthcare in London on Nov. 19-21, and learn more about our expanded capabilities.

Attending #ASH24? Stop by our booth (#1249) to learn how our solutions can help you advance your #hematology #drugdevelopment with our full-spectrum, end-to-end solutions spanning from early drug discovery support and #clinicaldevelopment, through market access and commercial strategy.

It is estimated that 37% of sites under-enroll in clinical trials and that 11% of sites fail to enroll a single patient. Our latest white paper explores how machine learning (ML) can proactively identify and engage these sites. Learn how predictive analytics and personalized outreach strategies can enhance site performance, reduce trial delays and optimize resource allocation. » https://bit.ly/3UI8CNN #machinelearning #analytics #clinicaltrials